A systematic review of medical mistrust measures

LD Williamson, CA Bigman - Patient education and counseling, 2018 - Elsevier
Objective Medical mistrust is seen as a barrier to health promotion and addressing health
disparities among marginalized populations. This study seeks to examine how medical …

Telemedicine in oncology and reimbursement policy during COVID-19 and beyond

SM Kircher, M Mulcahy, A Kalyan, CB Weldon… - Journal of the National …, 2020 - jnccn.org
The first confirmed case of coronavirus disease 2019 (COVID-19) in the United States was
reported on January 20, 2020. As of September 17, 2020, there were more than 6.6 million …

Improving enrollment of underrepresented racial and ethnic populations in heart failure trials: a call to action from the heart failure collaboratory

EM DeFilippis, M Echols, PB Adamson… - JAMA …, 2022 - jamanetwork.com
Importance Despite bearing a disproportionate burden of heart failure (HF), Black and
Hispanic individuals have been poorly represented in HF clinical trials. Underrepresentation …

Does discrimination breed mistrust? Examining the role of mediated and non-mediated discrimination experiences in medical mistrust

LD Williamson, MA Smith… - Journal of health …, 2019 - Taylor & Francis
Medical mistrust is associated with a decreased likelihood of engaging in various health
behaviors, including health utilization and preventive screening. Despite calls for research to …

Behavioral brittleness: The case for strategic behavioral public policy

R Schmidt, K Stenger - Behavioural Public Policy, 2024 - cambridge.org
Despite widespread recognition that behavioral public policy (BPP) needs to move beyond
nudging if the field is to achieve more significant impact, problem-solving approaches …

[HTML][HTML] Measuring the trustworthiness of health care organizations and systems

A Anderson, DM Griffith - The Milbank Quarterly, 2022 - ncbi.nlm.nih.gov
Across multiple fields of study, trust is defined as “a psychological state that determines a
person's willingness to be vulnerable under conditions of risk/uncertainty, and …

Exploring willingness to participate in clinical trials by ethnicity

KL Pariera, ST Murphy, J Meng… - Journal of racial and …, 2017 - Springer
Abstract African-Americans and Hispanic-Americans are disproportionately affected by
cancer, yet underrepresented in cancer clinical trials. Because of this, it is important to …

Disparities in awareness of and willingness to participate in cancer clinical trials between African American and White cancer survivors

G Kumar, J Kim, PA Farazi, H Wang, D Su - BMC cancer, 2022 - Springer
Abstract Background Cancer clinical trials (CCTs) are essential for cancer care, yet the
evidence is scarce when it comes to racial disparities in CCT participation among cancer …

[HTML][HTML] African American participation in cancer clinical trials

J Swaby, E Kaninjing, M Ogunsanya - ecancermedicalscience, 2021 - ncbi.nlm.nih.gov
Background According to the Food and Drug Administration, African Americans (AAs) have
been habitually underrepresented in cancer clinical trials (CCTs). This under-enrolment has …

Choosing channels, sources, and content for communicating prostate cancer information to black men: a systematic review of the literature

K Walsh-Childers, F Odedina, A Poitier… - American journal of …, 2018 - journals.sagepub.com
The purpose of this study was to identify effective channels, sources, and content
approaches for communicating prostate cancer prevention information to Black men. The …